$24.34
0.301.25%
In chiusura: Sep 11, 5:00 PM EST
$24.34
N/A
Post-mercato: Sep 11, 4:00 PM EST
Caris Life Sciences Inc
CAINASDAQ
Caris Life Sciences Earnings & Forecasts
Caris Life Sciences (CAI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Caris Life Sciences Guidance
Caris Life Sciences (CAI) ha pubblicato l'ultima guidance il agosto 5, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $1.03B - $1.04B per il periodo.
Rispetto alle previsioni precedenti, Caris Life Sciences ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Caris Life Sciences ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Caris Life Sciences. 7
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.01 | $-0.02 | $0.07 | $-0.11 |
| Actual | $0.00 | $0.00 | $0.28 | $0.08 |
| Surprise | -100.0% | +100.0% | +300.0% | +172.7% |
| Revenue | ||||
| Estimate | $237.0M | $209.5M | $280.9M | $173.7M |
| Actual | $263.7M | $216.2M | $292.9M | $216.8M |
| Surprise | +11.3% | +3.19% | +4.27% | +24.8% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.03 | $0.11 | $0.03 | $0.10 |
| Revenue | ||||
| Consensus | $254.7M | $292.9M | — | — |